Showing results 1 to 20 of 22
next >
| Issue Date | Title | Author(s) |
| Apr-2020 | Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors | Wang, Zhijie; Duan, Jianchun; Wang, Guoqiang; Zhao, Jing; Xu, Jiachen; Han, Jiefei; Zhao, Zhengyi; Zhao, Jun; Zhu, Bo; Zhuo, Minglei; Sun, Jianguo; Bai, Hua; Wan, Rui; Wang, Xin; Fei, Kailun; Wang, Shuhang; Zhao, Xiaochen; Zhang, Yuzi; Huang, Mengli; Huang, Depei; Qi, Chuang; Gao, Chan; Bai, Yuezong; Dong, Hua; Xiong, Lei; Tian, Yanhua; Wang, Di; Xu, Chunwei; Wang, Wenxian; Li, Junling; Hu, Xingsheng; Cai, Shangli; Wang, Jie |
| 2019 | Clinical features and outcomes of ALK rearranged non-small cell lung cancer with primary resistance to crizotinib | Ma, Di; Zhang, Yan; Xing, Puyuan; Hao, Xuezhi; Wang, Mengzhao; Wang, Yan; Shan, Li; Xin, Tao; Liang, Hongge; Du, Yang; Zhang, Zhaohui; Liang, Li; Li, Junling |
| 7-Jan-2025 | A cohort-based multi-omics identifies nuclear translocation of eIF5B /PD-L1/CD44 complex as the target to overcome Osimertinib resistance of ARID1A-deficient lung adenocarcinoma | Sun, Dantong; Hou, Helei; Feng, Feiyue; Wu, Weizheng; Tan, Jingyu; Xie, Tongji; Liu, Jiayu; Wang, Jinsong; Qian, Haili; Li, Junling; Xing, Puyuan |
| 13-Dec-2022 | Consumption of fish oil high-fat diet induces murine hair loss via epidermal fatty acid binding protein in skin macrophages | Hao, Jiaqing; Jin, Rong; Zeng, Jun; Hua, Yuan; Yorek, Matthew S.; Liu, Lianliang; Mandal, Anita; Li, Junling; Zheng, Huaiyu; Sun, Yanwen; Yi, Yanmei; Yin, Di; Zheng, Qi; Li, Xiaohong; Ng, Chin K.; Rouchka, Eric C.; Egilmez, Nejat K.; Jabbari, Ali; Li, Bing |
| May-2020 | Crizotinib vs platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer with different ROS1 fusion variants | Xu, Haiyan; Zhang, Quan; Liang, Li; Li, Junling; Liu, Zhefeng; Li, Weihua; Yang, Lu; Yang, Guangjian; Xu, Fei; Ying, Jianming; Zhang, Shucai; Wang, Yan |
| 6-Apr-2020 | Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial | Bi, Nan; Liu, Lipin; Liang, Jun; Wu, Shixiu; Chen, Ming; Lv, Changxing; Zhao, Lujun; Shi, Anhui; Jiang, Wei; Xu, Yaping; Zhou, Zongmei; Wang, Jingbo; Wang, Wenqing; Chen, Dongfu; Hui, Zhouguang; Lv, Jima; Zhang, Hongxing; Feng, Qinfu; Xiao, Zefen; Wang, Xin; Zhang, Tao; Yin, Weibo; Li, Junling; He, Jie; Wang, Luhua |
| Aug-2021 | Efficacy and Safety of Niraparib as Maintenance Treatment in Patients With Extensive-Stage SCLC After First-Line Chemotherapy: A Randomized, Double-Blind, Phase 3 Study | Ai, Xinghao; Pan, Yueyin; Shi, Jianhua; Yang, Nong; Liu, Chunling; Zhou, Jianying; Zhang, Xiaodong; Dong, Xiaorong; He, Jianxing; Li, Xiaoling; Chen, Gongyan; Li, Xingya; Zhang, Helong; Liao, Wangjun; Zhang, Yiping; Ma, Zhiyong; Jiang, Liyan; Cui, Jiuwei; Hu, Chunhong; Wang, Wei; Huang, Cheng; Zhao, Jun; Ding, Cuimin; Hu, Xiaohua; Wang, Kai; Gao, Beili; Song, Yong; Liu, Xiaoqing; Xiong, Jianping; Liu, Anwen; Li, Junling; Liu, Zhe; Li, Yinyin; Wang, Mengzhao; Zhang, Biao; Zhang, Dan; Lu, Shun |
| 2019 | Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in China | Xing, Puyuan; Wang, Shouzheng; Wang, Qiang; Ma, Di; Hao, Xuezhi; Wang, Mengzhao; Wang, Yan; Shan, Li; Xin, Tao; Liang, Li; Liang, Hongge; Du, Yang; Zhang, Zhaohui; Li, Junling |
| 31-May-2021 | Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma | Li, Teng; Pang, Xiaocong; Wang, Junyun; Wang, Shouzheng; Guo, Yiying; He, Ning; Xing, Puyuan; Li, Junling |
| 2017 | Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma | Zhai, Xiaoyu; Zheng, Qiwen; Yang, Lu; Zhu, Yixiang; Li, Junling; Liu, Yutao; Wang, Ziping |
| 2017 | Is there an optimal time to initiate adjuvant chemotherapy to predict benefit of survival in non-small cell lung cancer? | Liu, Yutao; Zhai, Xiaoyu; Li, Junling; Li, Zhiwen; Ma, Di; Wang, Ziping |
| 2015 | Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study | Shi, Yuankai; Li, Junling; Zhang, Shucai; Wang, Mengzhao; Yang, Shujun; Li, Ning; Wu, Gang; Liu, Wei; Liao, Guoqing; Cai, Kaican; Chen, Liang'an; Zheng, Meizhen; Yu, Ping; Wang, Xiuwen; Liu, Yunpeng; Guo, Qisen; Nie, Ligong; Liu, Jiwei; Han, Xiaohong |
| 15-Mar-2022 | A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non-Small Cell Lung for Cancer: a Multicenter Phase I/II Study | Zhou, Qing; Wu, Lin; Hu, Pei; An, Tongtong; Zhou, Jianying; Zhang, Li; Liu, Xiao-Qing; Luo, Feng; Zheng, Xin; Cheng, Ying; Yang, Nong; Li, Junling; Feng, Jifeng; Han, Baohui; Song, Yong; Wang, Kai; Fang, Jian; Zhao, Hong; Shu, Yongqian; Lin, Xiao-Yan; Chen, Zhihong; Gan, Bin; Xu, Wan-Hong; Tang, Wei; Zhang, Xiaoying; Yang, Jin-Ji; Xu, Xiao; Wu, Yi-Long |
| 2011 | Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification | Guo, Jun; Si, Lu; Kong, Yan; Flaherty, Keith T.; Xu, Xiaowei; Zhu, Yanyan; Corless, Christopher L.; Li, Li; Li, Haifu; Sheng, Xinan; Cui, Chuanliang; Chi, Zhihong; Li, Siming; Han, Mei; Mao, Lili; Lin, Xuede; Du, Nan; Zhang, Xiaoshi; Li, Junling; Wang, Baocheng; Qin, Shukui |
| 2019 | Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study | Liang, Hongge; Song, Xia; Zhang, Yuhui; Zhang, Shucai; Li, Fang; Fang, Jian; Li, Junling; Liang, Li; Nie, Ligong; Ma, Kewei; Zhang, Liangming; Wang, Xiaohong; Xu, Junjun; Wei, Yanxia; Wang, Jinghui; Song, Qi; Tian, Guangming; Mu, Yuxin; Gu, Yangchun; Yang, Lei; Sun, Ping; Zhong, Wei; Zhao, Jing; Xu, Yan; Chen, Minjiang; Wang, Mengzhao |
| 2016 | Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative | Ma, Di; Wang, Zheng; Yang, Lin; Mu, Xinlin; Wang, Yan; Zhao, Xinming; Li, Junling; Lin, Dongmei |
| 2015 | Responses to Crizotinib in Six Lung Adenocarcinoma Patients of ALK IHC-Positive and FISH-Negative | Ma, Di; Wang, Zheng; Yang, Lin; Mu, Xinlin; Wang, Yan; Zhao, Xinming; Li, Junling; Lin, Dongmei |
| 2019 | Safety and efficacy of abivertinib (AC0010), a third-generation EGFR tyrosine kinase inhibitor, in Chinese patients with EGFR-T790M positive non-small cell lung cancer (NCSLC). | Zhou, Qing; Wu, Lin; Feng, Luo; An, Tongtong; Cheng, Ying; Zhou, Jianying; Li, Junling; Feng, Ji Feng; Zhang, Li; Han, Baohui; Xu, Walson; Zhu, Lvyu; Xu, Li; Xu, Xiao; Luo, Feng Roger; Wu, Yi-Long |
| 1-Oct-2023 | Size-dependent chemical composition of atmospheric nanoparticles in urban Beijing during springtime | Chen, Yan; Deng, Chenjuan; Lei, Ting; Li, Junling; Lian, Chaofan; Li, Yiran; Zheng, Jun; Zhao, Jun; Wang, Dongbin; Wu, Zhijun; Wang, Lin; Li, Lei; Li, Hong; Gao, Jian; Jiang, Jingkun; Ge, Maofa; Wang, Weigang |
| 1-Oct-2023 | Size-dependent chemical composition of atmospheric nanoparticles in urban Beijing during springtime | Chen, Yan; Deng, Chenjuan; Lei, Ting; Li, Junling; Lian, Chaofan; Li, Yiran; Zheng, Jun; Zhao, Jun; Wang, Dongbin; Wu, Zhijun; Wang, Lin; Li, Lei; Li, Hong; Gao, Jian; Jiang, Jingkun; Ge, Maofa; Wang, Weigang |
